Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chiglitazar vs Sitagliptin in Type 2 Diabetes (CMAS)
NCT02173457Phase 3Completed
- Sponsor
- Akeso, Inc.
- Start
- Sep 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chiglitazar in type 2 diabetes mellitus (T2DM), sponsored by Akeso, Inc.. Started Sep 2014; status: completed.
02
Drugs
chiglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02173457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173457.